Counterpoint Mutual Funds’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$594K Buy
35,281
+8,668
+33% +$167K 0.05% 161
2026
Q2
$489K Sell
26,613
-13,512
-34% -$289K 0.05% 171
2026
Q1
$811K Buy
40,125
+13,605
+51% +$303K 0.12% 87
2025
Q4
$508K Buy
26,520
+5,765
+28% +$121K 0.04% 93
2025
Q3
$500K Sell
20,755
-22,424
-52% -$524K 0.04% 137
2025
Q2
$840K Sell
43,179
-13,730
-24% -$203K 0.07% 61
2025
Q1
$732K Buy
+56,909
New +$915K 0.1% 103
2024
Q4
– Sell
-12,327
Closed -$278K – 279
2024
Q3
$278K Buy
+12,327
New +$282K 0.05% 149
2023
Q2
– Sell
-5,655
Closed -$232K – 289
2023
Q1
$232K Buy
5,655
+2,351
+71% +$98.2K 0.2% 9
2022
Q4
$115K Buy
+3,304
New +$116K 0.12% 219
2022
Q2
– Sell
-630
Closed -$26K – 242
2022
Q1
$26K Buy
+630
New +$27.1K 0.02% 156

Other funds holding ADNT

Counterpoint Mutual Funds's ADNT Position: Q3 2026 in Review

Counterpoint Mutual Funds increased its Adient (ADNT) stake by 33% in Q3 2026, buying an estimated $167K and bringing the position to 35,281 shares worth $594K. The position accounts for 0.05% of the portfolio, ranked #161.

Counterpoint Mutual Funds first reported a position in ADNT in Q1 2022 and has held it in 11 quarters since. The position peaked at $840K in Q2 2025. 59 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.

  • Counterpoint Mutual Funds held 35,281 shares of Adient worth $594K as of Q3 2026.
  • Counterpoint Mutual Funds bought 8,668 Adient shares in Q3 2026, an estimated $167K.
  • Adient made up 0.05% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #161 holding.
  • Counterpoint Mutual Funds first reported a position in Adient in Q1 2022 and has held it in 11 quarters since.
  • Counterpoint Mutual Funds's Adient position peaked at $840K in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Adient as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.